In prostate cancer, a trial comparing conventional- versus high-dose conformal radiotherapy has shown that increasing the dose can improve outcome, with only slight increases in toxicity.
Related Articles
Impact Factor
Gazing at the crystal ball of European radiotherapy
Featured
How does treating the primary affect risk of a secondary?
Senza categoria